Reimbursement Effects on Enrollment in Obesity Treatment
The purpose of this study is to simulate what would occur if insurance reimbursement became available for obesity treatment but required that the individual meet defined performance milestones.
|Study Design:||Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||A Prospective Study to Determine the Effects of a Reimbursement Incentive on Enrollment and Outcomes in a Community Weight Control Program.|
- Proportion of inquirers who enroll in obesity treatment [ Time Frame: 16 months ] [ Designated as safety issue: No ]
- Class attendance [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
- Percent weight loss [ Time Frame: 12 weeks and 9 months ] [ Designated as safety issue: No ]
- Changes in medication dosages and costs [ Time Frame: 12 weeks and 9 months ] [ Designated as safety issue: No ]
- Visits to health care providers [ Time Frame: 12 weeks and 9 months ] [ Designated as safety issue: No ]
|Study Start Date:||June 2004|
|Study Completion Date:||December 2006|
|No Intervention: 1|
EatRight Program inquirers with BMI's of 30 kg/m2 or greater were told that they would have the possibility of being reimbursed 50% ($150) of their initial fee ($300) if certain conditions were met.
Behavioral: Simulated insurance reimbursement
Participants were told they would have the possibility of being reimbursed 50% ($150) of their initial fee ($300) if they: 1) paid the fee in advance or committed 3 monthly payments in advance, 2) attended 10 of 12 class sessions, and 3) lost at least 6% of their current body weight during the program.
This is a prospective study to determine whether a reimbursement incentive (the prospect of reimbursement of half of the out-of-pocket fee for participation in the UAB EatRight Weight Management Program, when it is contingent upon consistent Program participation and loss of 6% of initial body weight) is associated with (1) a higher rate of Program enrollment and (2) greater percent weight loss, greater reductions in medication dosages and costs, and fewer visits to health care providers after 12 weeks and 9 months.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00250510
|United States, Alabama|
|University of Alabama at Birmingham|
|Birmingham, Alabama, United States, 35294-3360|
|Principal Investigator:||Douglas C Heimburger, MD||University of Alabama at Birmingham|